Annual Current Liabilities
$15.24 M
+$2.86 M+23.14%
December 31, 2024
Summary
- As of March 10, 2025, JSPR annual total current liabilities is $15.24 million, with the most recent change of +$2.86 million (+23.14%) on December 31, 2024.
- During the last 3 years, JSPR annual current liabilities has risen by +$7.22 million (+89.99%).
- JSPR annual current liabilities is now at all-time high.
Performance
JSPR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$15.24 M
+$2.78 M+22.30%
December 31, 2024
Summary
- As of March 10, 2025, JSPR quarterly total current liabilities is $15.24 million, with the most recent change of +$2.78 million (+22.30%) on December 31, 2024.
- Over the past year, JSPR quarterly current liabilities has stayed the same.
- JSPR quarterly current liabilities is now at all-time high.
Performance
JSPR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
JSPR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.1% | 0.0% |
| 3 y3 years | +90.0% | +28.0% |
| 5 y5 years | +279.8% | +28.0% |
JSPR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +115.7% | at high | +155.3% |
| 5 y | 5-year | at high | +279.8% | at high | +279.8% |
| alltime | all time | at high | +279.8% | at high | +279.8% |
Jasper Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $15.24 M(+23.1%) | $15.24 M(+22.3%) |
| Sep 2024 | - | $12.46 M(+23.7%) |
| Jun 2024 | - | $10.07 M(+12.9%) |
| Mar 2024 | - | $8.92 M(-27.9%) |
| Dec 2023 | $12.37 M | $12.37 M(+3.9%) |
| Sep 2023 | - | $11.91 M(+32.7%) |
| Jun 2023 | - | $8.97 M(+13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $7.89 M(+11.7%) |
| Dec 2022 | $7.07 M(-11.9%) | $7.07 M(-4.8%) |
| Sep 2022 | - | $7.42 M(+12.1%) |
| Jun 2022 | - | $6.62 M(+10.9%) |
| Mar 2022 | - | $5.97 M(-25.6%) |
| Dec 2021 | $8.02 M(+99.9%) | $8.02 M(-12.4%) |
| Sep 2021 | - | $9.16 M(+128.3%) |
| Dec 2020 | $4.01 M | $4.01 M |
FAQ
- What is Jasper Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics annual current liabilities year-on-year change?
- What is Jasper Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly current liabilities year-on-year change?
What is Jasper Therapeutics annual total current liabilities?
The current annual current liabilities of JSPR is $15.24 M
What is the all time high annual current liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high annual total current liabilities is $15.24 M
What is Jasper Therapeutics annual current liabilities year-on-year change?
Over the past year, JSPR annual total current liabilities has changed by +$2.86 M (+23.14%)
What is Jasper Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of JSPR is $15.24 M
What is the all time high quarterly current liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly total current liabilities is $15.24 M
What is Jasper Therapeutics quarterly current liabilities year-on-year change?
Over the past year, JSPR quarterly total current liabilities has changed by $0.00 (0.00%)